Ascendis Pharma A (ASND) Return on Invested Capital (QoQ) (2021 - 2026)

Ascendis Pharma A (ASND) Return on Invested Capital (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn -
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn -
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn
7 Belite Bio 62.74 Bn 62.74 Bn -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn
10 Ascendis Pharma A 15.46 Bn 14.79 Bn 268.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 -427.00
Sep 30, 2025 -8.00
Jun 30, 2025 -8.00
Mar 31, 2025 -60.00
Dec 31, 2024 502.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 1.00
Dec 31, 2022 3.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00